ABNCoV2 cVLP based COVID-19 vaccine (AdaptVac)
- Generic Name
- ABNCoV2 cVLP based COVID-19 vaccine (AdaptVac)
ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2
- First Posted Date
- 2022-04-14
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- Bavarian Nordic
- Target Recruit Count
- 4205
- Registration Number
- NCT05329220
- Locations
- 🇺🇸
Accel Research Site - NeuroStudies.net, LLC, Decatur, Georgia, United States
🇺🇸DM Clinical Research, Sugar Land, Texas, United States
🇺🇸Meridian Clinical Research - Family Practice, Portsmouth, Virginia, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath